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Upon in vitro translation of mRNAs from slow (soleus) muscles of the mouse a hitherto undescribed translation product 
has been detected that was absent from fast sekeletal muscles and was termed pl9/6.8 according to its position in 2- 
dimensional gels. mRNA for p19/6.8 was also found in the ventricle of the heart. p19/6.8 was not detectable by Coomassie 
blue staining but could be characterised by fractionation of in vivo labelled muscle tissue. It was found to sediment with 
the particulate fraction at 14000 x g. The expression of p19/6.8 mRNA appears to be down-regulated in muscles with 
phasic activity. 
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1. INTRODUCTION 
In skeletal muscle, the diversity of fiber types is 
reflected by the pattern of polypeptide species of 
the muscle fibers. Many muscle proteins exist as 
slow and fast isoforms in different fibers (e.g. 
myosins, tropomyosins, troponins, Ca’+-Mg’+- 
ATPases), while others are found to be expressed 
exclusively in fast fibers like parvalbumin [l] or in 
slow fibers, like the type I proteins [2]. The dif- 
ferential expression of these proteins is thought to 
be controlled by the activity of the motor neuron 
supplying the muscle fiber [3]. 
Proteins that are normally only expressed in 
slow muscles can be induced in fast muscles by ar- 
tificial chronic stimulation [4,5]. Some 
neuromuscular diseases are accompanied by the 
expression of slow muscle specific proteins [6] in 
muscles that are purely fast in the absence of 
disease. Analysis of mRNAs from myotonic mus- 
cle of the mouse mutant ‘arrested development of 
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righting response’, ADR [7,8], led to the discovery 
of a translation product, termed p19/6.8 [9,10]. 
The distribution and some properties will be 
described in the present communication. 
2. MATERIALS AND METHODS 
For the origin of the myotonic mouse mutant ADR see [7,8]. 
Non-affected littermates were used as wildtype controls 
(genotype: +/adr?). RNA was extracted from shock-frozen 
muscles by homogenization in 4 M guanidinium thiocyanate 
and pelleted through a CsCl cushion [ 111. In vitro translation 
was done in a commercial (NEN, Dreieich) reticulocyte lysate 
according to the manufacturer’s instructions with minor 
modifications. 
Freshly dissected soleus muscle (+ /adr?) was incubated for 
6 h in 200~1 methionine free medium (DMEM) supplemented 
with 50 PM unlabelled methionine and 50 &i [“Slmethionine 
in a 5% CO2 atmosphere at 37°C. Proteins were extracted by 
grinding with mortar and pestle in 2% Triton X-100, 10 mM 
Tris-Cl, pH 7.6. The homogenates were sonicated and then 
shaken for 30 min. The supernatant after centrifugation at 
14000 x g was referred to as the soluble fraction, the remaining 
pellet, extracted with 8 M urea, was regarded as the insoluble 
fraction. 
Two-dimensional polyacrylamide gel electrophoresis (2D- 
PAGE) was carried out as described by O’Farrell [12] in a mini- 
electrophoresis chamber (Renner, Darmstadt). After staining 
with Coomassie brilliant blue or silver [13] the gels were pro- 
cessed for fluorography by immersing in Amplify (Amersham). 
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3. RESULTS 
Polypeptide p19/6.8 was one of the major in 
vitro translation products synthesized from RNAs 
a 
that were isolated from the adult soleus of mouse 
(fig.lb) or rat (fig.le). In contrast, the p1916.8 
translation product was below the detection limit 
in soleus from lo-day-old mice (fig.la) and fast 
Fig.1, 2D-pattern (only part of the gels is shown) of in vitro translated mouse (a-d) and rat (e) muscle RNAs. RNAs were from (a) 
M. soleus, 10 day; (b) M. soleus, 80 day; (c) M. vastus, 120 day; (d) ventricle; (e) M. soleus. Is, If, 2s, 2f, 3f, slow and fast isoforms 
of myosin light chains 1,2,3; PV, parvalbumin; arrow, p19/6.8. 
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Fig.2. ZD-PAGE of proteins extracted from a mouse soleus muscle that was “‘S-labelled in organ culture. Fluorograph (b,d) and silver- 
stained gels (a,c) of the soluble (a,b) and the insoluble (c,d) fraction is shown. Abbreviations used were the same as in fig.1. 
wildtype muscles of all ages (fig.lc). Furthermore, 
p19/6.8 mRNA was found in the ventricle of the 
heart (fig.ld). 
Soluble proteins extracted from a slow muscle 
after [35S]methionine labelling in vivo showed a 
similar pattern to major translation products, in- 
cluding p19/6.8 (fig.2b), however, p19/6.8 could 
not be detected on the same gel by silver staining 
(fig.2a). 
Polypeptide p1916.8 was found in the unsoluble 
fraction of silver-stained 2D-PAGE (fig.2c) but the 
specific activity (visually estimated by comparing 
p19/6.8 spots in silver-stained ZD-PAGE and 
fluorographs of the gels) was much lower. The 
identity of p19/6.8 in these 2D-PAGES was con- 
firmed by co-electrophoresis with in vitro syn- 
thesized 35S-labelled polypeptides (not shown). 
4. DISCUSSION 
In skeletal muscle of the mouse, p19/6.8 is only 
found in slow soleus muscle. Since this muscle con- 
sists of 50% type I and 50% type II (oxidative) 
fibers, and the fast M. tibialis anterior of 50% type 
II (oxidative) and 50% type II (glycolytic) [14] 
fibers, the presence of p1916.8 mRNA in the soleus 
and its absence in the tibialis anterior muscle sug- 
gests that in skeletal muscle ~1916.8 is expressed 
exclusively in type I fibers. In addition, in the rat 
soleus, which is composed of 70-90% type I fibers 
1151, the concentration of p19i6.8 mRNA is higher 
than in mouse soleus. p1916.8 is also found in the 
ventricle of the heart, which shares several contrac- 
tile proteins with slow skeletal muscles. For exam- 
ple, the slow myosin light chains are expressed 
both in slow skeletal muscle and in the ventricle 
1161. 
In contrast, in the diseased myotonic muscle, 
which is not a slow muscle with respect to 
physiological, histochemical, or biochemical 
properties [14], considerable amounts of p19/6.8 
mRNA are present and translated. In the same 
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muscle, mRNA coding for parvalbumin is down- 
regulated [9]. It is known, that parvalbumin con- 
centration is regulated via the activity of the mus- 
cle fiber membrane [3,17-191, and it seems 
possible that p19/6.8 is regulated in an opposite 
way by the same stimulus, i.e. excessive activity of 
the myotonic muscle. 
The function of p19/6.8 is unknown. It is 
neither a cytosolic protein nor a component of the 
myofibrils. On the other hand, newly synthesized, 
35S-labelled p1916.8 is soluble in Triton X-100, in- 
dicating that it is either membrane associated or 
free in the cytoplasm (fig.2a,b). Subsequently, it 
might become attached to a subcellular structure, 
thus losing its solubility. In conclusion, p19/6.8 is 
a protein regulated by muscle activity and 
restricted to slow type I fibers. It is a useful marker 
for the maturation of slow muscles and for muscle 
diseases affecting fiber type differentiation. 
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